DJIA 17,115.66 -57.02 -0.33%
NASDAQ 4,528.54 0.85 0.02%
S&P 500 1,988.02 -6.27 -0.31%
market minute promo

Epizyme (NASDAQ: EPZM)

25.54 0.04 (0.16%)

Quote as of


company name or ticker

Recent Quotes

EPZM $25.54 0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $25.45
Previous Close $25.50
Daily Range $25.22 - $26.04
52-Week Range $18.10 - $42.71
Market Cap $857.7M
P/E Ratio 26.29
Dividend (Yield) $0.00 (0.0%)
Volume 86,253
Average Daily Volume 447,884
Current FY EPS -$1.68

Sector

Industry

Epizyme (EPZM) Description

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. Website: http://www.epizyme.com/

News & Commentary

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

Epizyme (EPZM) Downgraded From Hold to Sell

UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play

Benzinga's Top Initiations

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Epizyme, Inc. Announces Resignation Of President And CFO Jason Rhodes

Epizyme Announces Resignation Of President And CFO Jason Rhodes

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Ca

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Capital

Monday Sector Leaders: Biotechnology, Drugs

Epizyme: Strong Early Data But Reserving Judgment Until Final Results

Zacks' Bull Of The Day: Epizyme

See More EPZM News...